Maureen Gannon
-
Research explores link between stem cell transplant, diabetes
Brian Engelhardt is studying why as many as 50 percent of stem cell transplant recipients develop diabetes. Read MoreJan 17, 2019
-
Therapeutic targets for diabetes
Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes. Read MoreMay 3, 2017
-
It takes two to tango: beta cell development
Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes. Read MoreJun 23, 2016
-
Gannon to chair ADA science session planning committee
Maureen Gannon, Ph.D., associate professor of Medicine, has been appointed chair of the American Diabetes Association (ADA) Scientific Session planning committee. Read MoreMay 5, 2016
-
New therapeutic target for diabetes
The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes. Read MoreAug 20, 2015
-
Boosting beta cells in diabetes
New findings suggest that it might be possible to treat diabetes by regenerating insulin-producing beta cells in the pancreas. Read MoreApr 20, 2015
-
Searching for beta cell stimulators
Vanderbilt researchers describe a new technique for identifying factors that stimulate the proliferation of pancreatic beta cells – factors that might offer therapeutic options for diabetes. Read MoreJan 13, 2014
-
Conference highlights latest developmental biology research
The annual Southeast Regional meeting of the Society for Developmental Biology, hosted by Vanderbilt for the first time since 2006, broke participant records with 163 investigators registered and 81 posters presented. Read MoreMay 23, 2013
-
Growth factor boosts beta cells
A growth factor may help grow transplantation-quality pancreas cells for treating diabetes. Read MoreOct 21, 2011